Karen Wilson – Trademark Portfolio
Entity Type: 01
Karen Wilson holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CHILDNEXUS. The owner is based in Los Angeles, CA.
11340 W Olympic Blvd., Ste-381
Los Angeles, CA 90064
Showing of trademarks Trademarks
Trademark Classifications
Karen Wilson's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Karen Wilson have?
Karen Wilson has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Karen Wilson file in?
Karen Wilson files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Karen Wilson's most well-known trademarks?
Karen Wilson's registered trademark portfolio includes well-known marks such as CHILDNEXUS. These are among 3 currently registered trademarks in the portfolio.
What is Karen Wilson's trademark registration success rate?
Karen Wilson has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.